GARY L KOBAYASHI
Allopathic & Osteopathic Physicians|Internal Medicine VISTA, CA NPI 1245303353
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine CA Amgen Inc. All categories
General Payments — all program years on this page
$383.10
- Category: General Payments
- Program years: PY2018–2019
- Record count: 23
- As of (CMS publication): 2026-01-23
Latest program year (PY2019): $116.48 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2019) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $116.48 | 8 |
By paying entity
Latest program year (PY2019) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $35.25 | 2 |
| GlaxoSmithKline, LLC. | $32.20 | 2 |
| Novo Nordisk AS | $13.47 | 1 |
| Janssen Pharmaceuticals, Inc | $12.43 | 1 |
| Astellas Pharma US Inc | $11.79 | 1 |
| SANOFI-AVENTIS U.S. LLC | $11.34 | 1 |
By program year
Records — PY2019 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 655641389 | Astellas Pharma US Inc | $11.79 | 03/07/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 658854435 | Janssen Pharmaceuticals, Inc | $12.43 | 02/28/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 662353357 | Amgen Inc. | $16.45 | 05/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 662353359 | Amgen Inc. | $18.80 | 03/05/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 668763849 | Novo Nordisk Inc | $13.47 | 01/11/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 671467825 | GlaxoSmithKline, LLC. | $21.23 | 01/31/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 671542807 | GlaxoSmithKline, LLC. | $10.97 | 12/19/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 694025987 | SANOFI-AVENTIS U.S. LLC | $11.34 | 04/23/2019 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2019_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.